Figure 3.
The novel monoclonal antibody is specific for 4-OHEN-DNA adducts. (A) The antibody shows high binding to 4-OHEN-ssDNA but undetectable or minimal binding to undamaged ssDNA. Different dilutions of the antibody were tested for binding to immobilized denatured antigens (50 ng/well) using a direct ELISA. (B) The antibody binds to 4-OHEN–DNA adducts but not to other types of DNA damage. Competitive inhibition of the antibody (1/10 000) binding to immobilized 4-OHEN-ssDNA (40 ng/well) by various competitors was performed using a competitive ELISA. (C) The antibody does not bind to a DNA adduct derived from endogenous estrogen (17β-estradiol). Competitive inhibition of the antibody (1/3000) binding to immobilized 4-OHEN-ssDNA (5 ng/well) by various competitors was performed using a competitive ELISA. oligo, oligonucleotide; dG-N2-6β-E2-oligo, oligonucleotide containing a deoxyguanosine-N2-6β-estradiol. Each point shows the mean (±SD) of three independent experiments.